Abstract
Disease and disorders of the central nervous system (CNS) are some of the most common ailments afflicting mankind, and it has been estimated that 32% of the population of the USA suffers from a disorder of the brain once in a lifetime, and 15% of the population over 18 suffer a mental disorder at least monthly. The use of natural products as psychotropic agents to alleviate mental disorders, or to create altered mental states, probably dates back to the dawn of time, when the first trial-and-error experiments by shamans or other experimenters led to the discovery of the effect of certain plant extracts on the mind. It is thus significant that the first alkaloid to be purified from a plant was the psychoactive analgesic morphine. Although there is extensive literature on the use of plants and plant extracts as hallucinogenic agents, the search for natural products for therapeutic psychotropic purposes is much less well-developed than, for example, the search for anticancer agents. Nevertheless, there are enough examples of the successful search for useful naturally-occurring psychotropic agents to ensure that a continued search is likely to be productive. This review will summarize results in the discovery of CNS-active natural products, with an emphasis on compounds that may be useful for therapeutic purposes.
Keywords: CNS-Active Agents, anticancer agents
Mini-Reviews in Organic Chemistry
Title: Natural Products as a Source of CNS-Active Agents
Volume: 1 Issue: 2
Author(s): Jason A. Clement, Brent J. Yoder and David G.I. Kingston
Affiliation:
Keywords: CNS-Active Agents, anticancer agents
Abstract: Disease and disorders of the central nervous system (CNS) are some of the most common ailments afflicting mankind, and it has been estimated that 32% of the population of the USA suffers from a disorder of the brain once in a lifetime, and 15% of the population over 18 suffer a mental disorder at least monthly. The use of natural products as psychotropic agents to alleviate mental disorders, or to create altered mental states, probably dates back to the dawn of time, when the first trial-and-error experiments by shamans or other experimenters led to the discovery of the effect of certain plant extracts on the mind. It is thus significant that the first alkaloid to be purified from a plant was the psychoactive analgesic morphine. Although there is extensive literature on the use of plants and plant extracts as hallucinogenic agents, the search for natural products for therapeutic psychotropic purposes is much less well-developed than, for example, the search for anticancer agents. Nevertheless, there are enough examples of the successful search for useful naturally-occurring psychotropic agents to ensure that a continued search is likely to be productive. This review will summarize results in the discovery of CNS-active natural products, with an emphasis on compounds that may be useful for therapeutic purposes.
Export Options
About this article
Cite this article as:
Clement A. Jason, Yoder J. Brent and Kingston G.I. David, Natural Products as a Source of CNS-Active Agents, Mini-Reviews in Organic Chemistry 2004; 1 (2) . https://dx.doi.org/10.2174/1570193043488872
DOI https://dx.doi.org/10.2174/1570193043488872 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
Call for Papers in Thematic Issues
Applications of Molecular Descriptors in Physicochemical Properties Research of Organic Compounds
Chemical graph theory is concerned with all aspects of the application of graph theory to various areas of chemistry, including organic, theoretical, mathematical, and computational chemistry, as well as in bioinformatics and computational biology. By the use of the term chemical it is emphasized that one is allowed in chemical ...read more
Exploring New Frontiers in Anti-inflammatory Treatment with Small Molecule Compounds
This thematic issue is dedicated to the latest advancements and research breakthroughs in the realm of anti-inflammatory pharmacotherapy. With inflammation playing a critical role in numerous chronic conditions such as cardiovascular diseases, diabetes, and autoimmune disorders, there is an urgent need for more targeted, effective, and safer anti-inflammatory treatments. This ...read more
Navigating the 2D Universe in Organic Chemistry
This special issue explores the transformative impact of two-dimensional (2D) materials on the realm of organic chemistry, unraveling new possibilities for synthesis, functionalization, and applications of organic compounds. Focused on the unique chemistry within this novel dimension, the issue highlights breakthroughs in the field of 2D organic chemistry. Contributions are ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Valproic Acid in the Complex Therapy of Malignant Tumors
Current Drug Targets Non-Selective Cation Channel Blockers: Potential Use in Nervous System Basic Research and Therapeutics
Mini-Reviews in Medicinal Chemistry Abnormal Functional and Structural Asymmetry as Biomarker for Schizophrenia
Current Topics in Medicinal Chemistry Pediatric Catatonia: Updating An Old Syndrome in Young People
Current Psychiatry Reviews Human Endometrial and Ovarian Cancer Cells: Histone Deacetylase Inhibitors Exhibit Antiproliferative Activity, Potently Induce Cell Cycle Arrest, and Stimulate Apoptosis
Current Medicinal Chemistry Parkinson Disease Genetics: A "Continuum" from Mendelian to Multifactorial Inheritance
Current Molecular Medicine Synaptic Plasticity, Metaplasticity and Depression
Current Neuropharmacology SIRT1 Promotes Neuronal Fortification in Neurodegenerative Diseases through Attenuation of Pathological Hallmarks and Enhancement of Cellular Lifespan
Current Neuropharmacology Sao Paulo Research Conference on Molecular Medicine and Pharmacogenetics, A Joint Meeting with the IUPHAR Sub-Committee on Pharmacogenetics and the Brazilian Pharmacogenetics Network, Sao Paulo, Brazil, September 18-20, 2008
Current Pharmacogenomics and Personalized Medicine Carbonic Anhydrase Inhibitors as Anticonvulsant Agents
Current Topics in Medicinal Chemistry Menthone Semicarbazides and Thiosemicarbazides as Anticonvulsant Agents
Medicinal Chemistry A Healthy Gut for a Healthy Brain: Preclinical, Clinical and Regulatory Aspects
Current Neuropharmacology Potassium Channel Blockers and Openers as CNS Neurologic Therapeutic Agents
Recent Patents on CNS Drug Discovery (Discontinued) Interleukin-1β Plays a Role in the Activation of Peripheral Leukocytes after Blood-Brain Barrier Rupture in the Course of Subarachnoid Hemorrhage
Current Neurovascular Research Metabotropic Glutamate Receptors in the Control of Neuronal Activity and as Targets for Development of Anti-Epileptogenic Drugs
Current Medicinal Chemistry Process Optimization for Extraction of Phytochemicals from <i>Ficus racemosa</i>: Phytochemical Extraction
The Natural Products Journal Revised Genetic Classification of Limb Girdle Muscular Dystrophies
Current Molecular Medicine Current Pharmaceutical Treatments and Alternative Therapies of Parkinson’s Disease
Current Neuropharmacology Synthesis and Analysis of Anticonvulsant Activities of New 4-[2-(4- alkoxybenzylamino)ethyl]-2H-1,2,4-triazol-3(4H)-one Derivatives
Letters in Drug Design & Discovery Medications not Intended for Treatment of Dyslipidemias and with a Variable Effect on Lipids
Current Pharmaceutical Design